Zhejiang Jingxin Pharmaceutical Co., Ltd.

SZSE:002020.SZ

12.55 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002
Operating Activities:
Net Income 618.898667.823614.704653.327521.948371.488267.026216.729166.617107.0864.34831.67929.1212.963.972-18.2551.45410.47118.45525.79125.40522.282
Depreciation & Amortization 221.467166.87143.552123.203106.20590.57586.70779.95858.86750.59142.44540.9938.98738.22338.79137.37428.13823.03913.4398.5145.6590
Deferred Income Tax 2.839-12.218-5.75831.009-0.139-9.863-4.635-1.744-9.1540000000000000
Stock Based Compensation 0000000000000000000000
Change In Working Capital -45.01821.349-391.743-120.919-42.2797.512-137.075-60.798-74.75851.169-12.446-32.061-17.314-14.26873.561-24.378-137.913-6.40426.196-32.2059.9310
Accounts Receivables -93.479-250.892-208.58334.443-170.305-136.632-126.779-116.848-141.281-34.046-30.961-108.7450000000000
Inventory 123.042-102.95-147.791-82.695-60.126-68.748-44.741-2.848-73.42-12.564-5.691-28.79-5.061-47.8349.60729.1577.25-65.484-4.205-25.7218.6120
Accounts Payables -74.58387.409-41.844-103.676188.3313.28339.0860.642149.0970000000000000
Other Working Capital 0-12.2186.47531.009-0.139166.26-92.334-57.95-1.33863.733-6.754-3.271-12.25433.56663.954-53.535-145.16359.07930.4-6.4841.3190
Other Non Cash Items 514.457-0.263-1.489-142.4-50.583-36.172168.34916.806-6.0331.64816.68419.66918.62122.63319.05635.24320.726-28.5523.7314.3315.182-22.282
Operating Cash Flow 824.692855.778365.024513.211535.301523.403385.007252.694144.693210.488111.03260.27769.41359.548135.3829.984-87.596-1.44661.826.4346.17645.498
Investing Activities:
Investments In Property Plant And Equipment -519.515-515.573-404.434-334.001-337.334-242.193-112.189-95.263-114.307-94.746-108.279-83.511-71.859-155.868-20.183-43.812-54.849-91.303-134.671-98.106-71.191-47.793
Acquisitions Net 10.2655.2168.2562.444-1.8640115.818-31.508-259.1230.462000000-1.791.8840000
Purchases Of Investments -1,175.196-1,058.027-861.667-2,170-2,145-2,853.305-2,231.877-847.759-430.785-39800-24.179000-8-600-3.5-0.1
Sales Maturities Of Investments 915833.9481,407.8642,977.9812,267.4872,920.551,039.457543.861487.4810.621000017.05617.2557.8290.10000
Other Investing Activites -0-3.222-5.33-12.52.5022.754-112.1896.9220.288-0.8511.6190.9157.2129.9190.73615.0879.4-91.3031.6230.011-71.1912.401
Investing Cash Flow -769.446-737.659144.688463.925-214.209-172.194-1,300.981-423.748-316.446-492.514-106.66-82.596-88.826-145.949-2.391-11.4752.68-96.623-133.048-98.096-74.691-45.493
Financing Activities:
Debt Repayment -35.002-150-300.321-358.756-155-143.23-130-370.93-161.971-393.685-724.151-757.592-435.012-236.3-498-333-268.5-249.559-27-128-86.65-81.8
Common Stock Issued 000200.98649.29390000000000000000
Common Stock Repurchased 000-200.986-235.516-267.4090000000000000000
Dividends Paid -258.309-258.309-231.426-231.943-205.848-142.811-63.977-49.843-50.31-30.447-31.995-41.454-22.542-18.635-23.603-38.548-17.648-11.536-18.657-4.997-4.757-3.992
Other Financing Activities -3.968220.53653.33996.794321.797-135.2391,187.314509.284440.373795.49689.644678.53739.446317.409412.3330.4395.17365.60395.82276.042117.01109.058
Financing Cash Flow -245.608-188.032120.847-497.379-226.341-278.05993.33688.511228.092371.359-66.501-120.516281.89262.473-109.303-41.148109.022104.50750.163143.04525.60323.266
Other Information:
Effect Of Forex Changes On Cash 2.71414.867-3.753-9.9471.7823.331-5.6183.4483.810.137-1.035-0.396-0.775-1.411-0.285-0.089-1.137-0.436-0.429-0.167-0.039-0.005
Net Change In Cash -77.831-55.046626.806469.8196.53376.49171.745-79.09560.1589.47-63.164-143.232261.704-25.33923.4-22.72822.976.002-21.49451.212-2.9523.266
Cash At End Of Period 1,410.6441,463.6671,512.835886.029416.219319.409242.918171.173250.268190.118100.648163.811307.04345.33970.67747.27870.00647.03641.03462.52811.31623.266